Stephen Hahn’s history in healthcare industry leaves open questions of ethics and priorities WASHINGTON – President Trump is expected to announce ... Read More
G1 Therapeutics Stock Value Surges 11% — It Pays To Have Sharpless’ Ear WASHINGTON — G1 Therapeutics, the biotech company ... Read More
SITE ARCHIVED:
Restore Public Trust is now Accountable.US. This website will no longer be updated and has been permanently archived. For the latest accountability and transparency updates please visit us at Accountable.US.